Tommaso Trenti, MD
Department of Laboratory Medicine and Pathology, University Hospital and Healthcare Trust, Modena, Italy
Tommaso Trenti graduated from the Medical School of the University of Modena as Medicine Doctor, is specialized in Clinical Toxicology, Gastroenterology and Clinical Biochemistry. His postdoctoral training was performed mainly at the University of Modena and Reggio Emilia with a research grant in London at the Medical Research Council at Toxicology Unit.
He was appointed Medical Director of the Laboratory of Clinical Biochemistry and Microbiology at Modena Health Trust in 2002 and in 2004 as Director of the Department of Clinical Pathology. At present he is Director of the Medicine Laboratory and Pathology Department both at University Hospital and Healthcare Trust in Modena, Italy.
Dr Trenti's research has been devoted to the study of molecular toxicology in experimental models as well in clinical setting and to therapeutic drug monitoring, at the present to molecular aspects of laboratory medicine in Oncology and Autoimmunity diseases as evaluation of physiopathology and biomarkers utilization in clinical practice. His studies are also focused on the application of Evidence Based Medicine to Medicine by production of systematic reviews and guidelines to advance diagnosis in clinical practice. Clinical Governance as continuous improvement of the quality and standards of care is one of his subsidiary interests.
In these areas he published as principal investigator or co-investigator numerous papers that can be accessed in PubMed. Further he was speakers in several national and international scientific meetings and member of scientific committee.
Dr. Tommaso Trenti has been involved in national working groups of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (Sibioc- Medicina di Laboratorio), leading at present the Autoimmunity study group and previously the EBLM group. He was appointed in international working groups of the International Federation for Clinical Chemistry (IFCC).